A Phase 2 Open-Label Study of HTX-011 Via Individualized Dosing Administration for Postoperative Analgesia Following Unilateral Simple Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Aprepitant
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Heron Therapeutics
- 02 Jan 2019 Aprepitant drug has been added in the study and two treatment arms has been added. also patient number also increased.
- 02 Jan 2019 Planned number of patients changed from 30 to 60.
- 02 Jan 2019 Planned End Date changed from 2 Jan 2019 to 7 Feb 2019.